Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inotec AMD is a medical technology company headquartered in Cambridge, UK, that specializes in advanced wound care solutions. The company is best known for its NATROX® O₂ system, a wearable device that delivers continuous topical oxygen therapy (cTOT) to treat chronic, non-healing wounds. This technology is specifically designed to address conditions such as diabetic foot ulcers and venous leg ulcers by stimulating the body's natural healing processes through increased oxygenation. Inotec AMD's products are used globally by healthcare professionals to improve healing rates and reduce the risk of amputations in high-risk patient populations. The company continues to expand its evidence base through clinical trials and is focused on integrating digital monitoring into its wound care platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inotec.